Detalhe da pesquisa
1.
Intramuscular AZD7442 (Tixagevimab-Cilgavimab) for Prevention of Covid-19.
N Engl J Med
; 386(23): 2188-2200, 2022 06 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35443106
2.
Accelerating therapeutics development during a pandemic: population pharmacokinetics of the long-acting antibody combination AZD7442 (tixagevimab/cilgavimab) in the prophylaxis and treatment of COVID-19.
Antimicrob Agents Chemother
; 68(5): e0158723, 2024 May 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38534112
3.
Safety, Tolerability and Pharmacokinetics of Half-Life Extended Severe Acute Respiratory Syndrome Coronavirus 2 Neutralizing Monoclonal Antibodies AZD7442 (Tixagevimab-Cilgavimab) in Healthy Adults.
J Infect Dis
; 227(10): 1153-1163, 2023 05 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36683419
4.
AZD7442 (Tixagevimab/Cilgavimab) for Post-Exposure Prophylaxis of Symptomatic Coronavirus Disease 2019.
Clin Infect Dis
; 76(7): 1247-1256, 2023 04 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36411267
5.
Single-Dose Nirsevimab for Prevention of RSV in Preterm Infants.
N Engl J Med
; 383(5): 415-425, 2020 07 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-32726528
6.
Performance of the Cepheid Methicillin-Resistant Staphylococcus aureus/S. aureus Skin and Soft Tissue Infection PCR Assay on Respiratory Samples from Mechanically Ventilated Patients for S. aureus Screening during the Phase 2 Double-Blind SAATELLITE Study.
J Clin Microbiol
; 60(7): e0034722, 2022 07 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-35758652
7.
Safety, efficacy, and pharmacokinetics of gremubamab (MEDI3902), an anti-Pseudomonas aeruginosa bispecific human monoclonal antibody, in P. aeruginosa-colonised, mechanically ventilated intensive care unit patients: a randomised controlled trial.
Crit Care
; 26(1): 355, 2022 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36380312
8.
Global Molecular Epidemiology of Respiratory Syncytial Virus from the 2017-2018 INFORM-RSV Study.
J Clin Microbiol
; 59(1)2020 12 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-33087438
9.
Microbial burden and viral exacerbations in a longitudinal multicenter COPD cohort.
Respir Res
; 21(1): 77, 2020 Mar 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-32228581
10.
Global molecular diversity of RSV - the "INFORM RSV" study.
BMC Infect Dis
; 20(1): 450, 2020 Jun 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-32591017
11.
Respiratory syncytial virus-associated illness in adults with advanced chronic obstructive pulmonary disease and/or congestive heart failure.
J Med Virol
; 91(1): 65-71, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30132922
12.
Prevalence and Significance of Substitutions in the Fusion Protein of Respiratory Syncytial Virus Resulting in Neutralization Escape From Antibody MEDI8897.
J Infect Dis
; 218(4): 572-580, 2018 07 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-29617879
13.
Prevalence of IgG and Neutralizing Antibodies against Staphylococcus aureus Alpha-Toxin in Healthy Human Subjects and Diverse Patient Populations.
Infect Immun
; 86(3)2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29263109
14.
An Adjuvanted, Postfusion F Protein-Based Vaccine Did Not Prevent Respiratory Syncytial Virus Illness in Older Adults.
J Infect Dis
; 216(11): 1362-1370, 2017 12 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29029260
15.
Safety, Tolerability, and Pharmacokinetics of MEDI8897, the Respiratory Syncytial Virus Prefusion F-Targeting Monoclonal Antibody with an Extended Half-Life, in Healthy Adults.
Antimicrob Agents Chemother
; 61(3)2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-27956428
16.
Safety, Tolerability, and Pharmacokinetics of MEDI4893, an Investigational, Extended-Half-Life, Anti-Staphylococcus aureus Alpha-Toxin Human Monoclonal Antibody, in Healthy Adults.
Antimicrob Agents Chemother
; 61(1)2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27795368
17.
The SAATELLITE and EVADE Clinical Studies Within the COMBACTE Consortium: A Public-Private Collaborative Effort in Designing and Performing Clinical Trials for Novel Antibacterial Drugs to Prevent Nosocomial Pneumonia.
Clin Infect Dis
; 63 Suppl 2: S46-51, 2016 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27481953
18.
Staphylococcus aureus Alpha-Toxin Is Conserved among Diverse Hospital Respiratory Isolates Collected from a Global Surveillance Study and Is Neutralized by Monoclonal Antibody MEDI4893.
Antimicrob Agents Chemother
; 60(9): 5312-21, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27324766
19.
Characterization of alpha-toxin hla gene variants, alpha-toxin expression levels, and levels of antibody to alpha-toxin in hemodialysis and postsurgical patients with Staphylococcus aureus bacteremia.
J Clin Microbiol
; 53(1): 227-36, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25392350
20.
Efficacy, Safety, and Pharmacokinetics of AZD7442 (Tixagevimab/Cilgavimab) for Prevention of Symptomatic COVID-19: 15-Month Final Analysis of the PROVENT and STORM CHASER Trials.
Infect Dis Ther
; 2024 May 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38703336